Warren Volles
Fortuna: 4 M $ al 31/08/2026
Fortuna: 4 M $ al 31/08/2026
Warren Volles is the founder of Ipraxus Legal.
Current job includes Chief Legal Officer & General Counsel at Biohaven Ltd. since 2019.
Former jobs include Member-Legal Department at Bristol Myers Squibb Co. from 2002 to 2016 and Principal at The Dow Chemical Co. Education includes a doctorate from Pace University and an undergraduate degree from the University of Connecticut.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOHAVEN LTD. 0,16 % | 09/07/2026 | 248.212 ( 0,16 % ) | 4 M $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOHAVEN LTD. | Consejero General | 01/06/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2016 |
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Dow Chemical Co.
The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biohaven Ltd.
Biohaven Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.